Fujirebio Diagnostics, Inc., a leading player in the diagnostics industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1950, the company has established itself as a pioneer in the development of innovative diagnostic solutions, particularly in the fields of oncology and infectious diseases. Fujirebio is renowned for its advanced biomarker technologies and high-quality assays, which are integral to disease detection and monitoring. Their flagship products, including the Lumipulse® platform, stand out for their precision and reliability, catering to the evolving needs of healthcare professionals. With a strong market position, Fujirebio has achieved significant milestones, including numerous regulatory approvals and partnerships that enhance its global reach. The company continues to drive advancements in diagnostics, contributing to improved patient outcomes worldwide.
We don't have data for Fujirebio Diagnostics, Inc., but we can show you information about their parent organization instead.
View parent company